{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:47:07Z","timestamp":1790455627942,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10549-019-05338-1","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T06:19:31Z","timestamp":1562393971000},"page":"705-711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Mammographic screening in male patients at high risk for breast cancer: is it worth it?"],"prefix":"10.1007","volume":"177","author":[{"given":"Maria Adele","family":"Marino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca","family":"Gucalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Leithner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daly","family":"Avendano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Bernard-Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Pinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4012-2470","authenticated-orcid":false,"given":"Maxine S.","family":"Jochelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,6]]},"reference":[{"issue":"5","key":"5338_CR1","doi-asserted-by":"publisher","first-page":"e997","DOI":"10.1016\/j.clbc.2018.06.013","volume":"18","author":"N Liu","year":"2018","unstructured":"Liu N, Johnson KJ, Ma CX (2018) Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer 18(5):e997\u2013e1002","journal-title":"Clin Breast Cancer"},{"key":"5338_CR2","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1200\/JCO.2009.25.5729","volume":"28","author":"LA Korde","year":"2010","unstructured":"Korde LA, Zujewski JA, Kamin L et al (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol Off J Am Soc Clin Oncol 28:2114\u20132122. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.25.5729","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5338_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","volume":"22","author":"A Liede","year":"2004","unstructured":"Liede A, Karlan BY, Narod SA (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol Off J Am Soc Clin Oncol 22:735\u2013742. \n                    https:\/\/doi.org\/10.1200\/JCO.2004.05.055","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5338_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer H, van den Ouweland A, Klijn J et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55\u201359. \n                    https:\/\/doi.org\/10.1038\/ng879","journal-title":"Nat Genet"},{"key":"5338_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3322\/canjclin.37.4.246","volume":"37","author":"DB Evans","year":"1987","unstructured":"Evans DB, Crichlow RW (1987) Carcinoma of the male breast and Klinefelter\u2019s syndrome: is there an association? CA Cancer J Clin 37:246\u2013251","journal-title":"CA Cancer J Clin"},{"key":"5338_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.breast.2013.02.005","volume":"22","author":"X-F Yu","year":"2013","unstructured":"Yu X-F, Feng W-L, Miao L-L et al (2013) The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study. Breast Edinb Scotl 22:824\u2013827. \n                    https:\/\/doi.org\/10.1016\/j.breast.2013.02.005","journal-title":"Breast Edinb Scotl"},{"key":"5338_CR7","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1158\/1078-0432.CCR-15-2840","volume":"22","author":"S Piscuoglio","year":"2016","unstructured":"Piscuoglio S, Ng CKY, Murray MP et al (2016) The genomic landscape of male breast cancers. Clin Cancer Res Off J Am Assoc Cancer Res 22:4045\u20134056. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2840","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"5338_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejca.2017.01.034","volume":"82","author":"MA Vermeulen","year":"2017","unstructured":"Vermeulen MA, Slaets L, Cardoso F et al (2017) Pathological characterisation of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program. Eur J Cancer Oxf Engl 82:219\u2013227. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2017.01.034","journal-title":"Eur J Cancer Oxf Engl"},{"key":"5338_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/annonc\/mdx651","volume":"29","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Bartlett JMS, Slaets L et al (2018) Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program. Ann Oncol Off J Eur Soc Med Oncol 29:405\u2013417. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdx651","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"5338_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA Cancer J Clin"},{"key":"5338_CR11","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) (2018) Genetic\/familial high-risk assessment\u2014breast and ovarian, version 1. \n                    https:\/\/www.tri-kobe.org\/nccn\/guideline\/gynecological\/english\/genetic_familial.pdf\n                    \n                  . (n.d.)"},{"key":"5338_CR12","unstructured":"D\u2019Orsi CJ, Sickles EA, Mendelson EB, Morris EA et al (2013) ACR BI-RADS\u00ae atlas, breast imaging reporting and data system. American College of Radiology, Reston, VA. \n                    http:\/\/www.acr.org\/~\/media\/ACR\/Documents\/PDF\/QualitySafety\/Resources\/BIRADS\/BIRADS%20V5%20Changes.pdf\n                    \n                  . Accessed 20 Sep 2015"},{"key":"5338_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/jmg.37.3.203","volume":"37","author":"DM Eccles","year":"2000","unstructured":"Eccles DM, Evans DG, Mackay J (2000) Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). J Med Genet 37:203\u2013209","journal-title":"J Med Genet"},{"key":"5338_CR14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","volume":"46","author":"F Sardanelli","year":"2010","unstructured":"Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296\u20131316. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2010.02.015","journal-title":"Eur J Cancer"},{"key":"5338_CR15","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/S0959-8049(98)00288-3","volume":"34","author":"HF Vasen","year":"1998","unstructured":"Vasen HF, Haites NE, Evans DG et al (1998) Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. Eur J Cancer Oxf Engl 34:1922\u20131926","journal-title":"Eur J Cancer Oxf Engl"},{"key":"5338_CR16","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/jmg.39.12.865","volume":"39","author":"DGR Evans","year":"2002","unstructured":"Evans DGR, Lalloo F (2002) Risk assessment and management of high risk familial breast cancer. J Med Genet 39:865\u2013871","journal-title":"J Med Genet"},{"key":"5338_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1023\/A:1008389021382","volume":"9","author":"F Eisinger","year":"1998","unstructured":"Eisinger F, Alby N, Bremond A et al (1998) Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee. Ann Oncol Off J Eur Soc Med Oncol 9:939\u2013950","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"5338_CR18","first-page":"104","volume":"45","author":"E Warner","year":"1999","unstructured":"Warner E, Heisey RE, Goel V et al (1999) Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer. Can Fam Physician Med Fam Can 45:104\u2013112","journal-title":"Can Fam Physician Med Fam Can"},{"key":"5338_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00508-012-0173-6","volume":"124","author":"CF Singer","year":"2012","unstructured":"Singer CF, Tea M-K, Pristauz G et al (2012) Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families. Wien Klin Wochenschr 124:334\u2013339. \n                    https:\/\/doi.org\/10.1007\/s00508-012-0173-6","journal-title":"Wien Klin Wochenschr"},{"key":"5338_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1155\/1999\/920109","volume":"15","author":"P M\u00f8ller","year":"1999","unstructured":"M\u00f8ller P, Evans G, Haites N et al (1999) Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer. Dis Mark 15:207\u2013211","journal-title":"Dis Mark"},{"key":"5338_CR21","doi-asserted-by":"publisher","first-page":"8469","DOI":"10.1200\/JCO.2004.00.4960","volume":"23","author":"CK Kuhl","year":"2005","unstructured":"Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 23:8469\u20138476. \n                    https:\/\/doi.org\/10.1200\/JCO.2004.00.4960","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5338_CR22","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","volume":"365","author":"MO Leach","year":"2005","unstructured":"Leach MO, Boggis CRM, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet Lond Engl 365:1769\u20131778. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(05)66481-1","journal-title":"Lancet Lond Engl"},{"key":"5338_CR23","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","volume":"28","author":"C Kuhl","year":"2010","unstructured":"Kuhl C, Weigel S, Schrading S et al (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol Off J Am Soc Clin Oncol 28:1450\u20131457. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.23.0839","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5338_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1148\/radiol.2302030360","volume":"230","author":"RJ Brenner","year":"2004","unstructured":"Brenner RJ, Weitzel JN, Hansen N, Boasberg P (2004) Screening-detected breast cancer in a man with BRCA2 mutation: case report. Radiology 230:553\u2013555. \n                    https:\/\/doi.org\/10.1148\/radiol.2302030360","journal-title":"Radiology"},{"key":"5338_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2214\/ajr.146.1.127","volume":"146","author":"DD Dershaw","year":"1986","unstructured":"Dershaw DD (1986) Male mammography. AJR Am J Roentgenol 146:127\u2013131. \n                    https:\/\/doi.org\/10.2214\/ajr.146.1.127","journal-title":"AJR Am J Roentgenol"},{"key":"5338_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2214\/ajr.160.2.8424331","volume":"160","author":"DD Dershaw","year":"1993","unstructured":"Dershaw DD, Borgen PI, Deutch BM, Liberman L (1993) Mammographic findings in men with breast cancer. AJR Am J Roentgenol 160:267\u2013270. \n                    https:\/\/doi.org\/10.2214\/ajr.160.2.8424331","journal-title":"AJR Am J Roentgenol"},{"key":"5338_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1524-4741.2011.01185.x","volume":"18","author":"BC Freedman","year":"2012","unstructured":"Freedman BC, Keto J, Rosenbaum Smith SM (2012) Screening mammography in men with BRCA mutations: is there a role? Breast J 18:73\u201375. \n                    https:\/\/doi.org\/10.1111\/j.1524-4741.2011.01185.x","journal-title":"Breast J"},{"key":"5338_CR28","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2214\/AJR.08.1076","volume":"191","author":"J Mathew","year":"2008","unstructured":"Mathew J, Perkins GH, Stephens T et al (2008) Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients. Am J Roentgenol 191:1631\u20131639. \n                    https:\/\/doi.org\/10.2214\/AJR.08.1076","journal-title":"Am J Roentgenol"},{"key":"5338_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1200\/JCO.2009.23.8162","volume":"28","author":"WF Anderson","year":"2010","unstructured":"Anderson WF, Jatoi I, Tse J, Rosenberg PS (2010) Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 28:232\u2013239. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.23.8162","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5338_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, van\u2019t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591\u2013602. \n                    https:\/\/doi.org\/10.1038\/nrc1670","journal-title":"Nat Rev Cancer"},{"key":"5338_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ (2003) The pathogenesis of cancer metastasis: the \u201cseed and soil\u201d hypothesis revisited. Nat Rev Cancer 3:453\u2013458. \n                    https:\/\/doi.org\/10.1038\/nrc1098","journal-title":"Nat Rev Cancer"},{"key":"5338_CR32","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1200\/JCO.1994.12.10.2229","volume":"12","author":"S Hellman","year":"1994","unstructured":"Hellman S (1994) Karnofsky memorial lecture. Natural history of small breast cancers. J Clin Oncol Off J Am Soc Clin Oncol 12:2229\u20132234. \n                    https:\/\/doi.org\/10.1200\/JCO.1994.12.10.2229","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5338_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/cncr.10742","volume":"95","author":"JS Michaelson","year":"2002","unstructured":"Michaelson JS, Silverstein M, Wyatt J et al (2002) Predicting the survival of patients with breast carcinoma using tumor size. Cancer 95:713\u2013723. \n                    https:\/\/doi.org\/10.1002\/cncr.10742","journal-title":"Cancer"},{"key":"5338_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmri.26732","volume":"1","author":"P Gibbs","year":"2019","unstructured":"Gibbs P, Onishi N, Sadinski M et al (2019) Characterization of sub-1\u00a0cm breast lesions using radiomics analysis. J Magn Reson Imaging 1:1. \n                    https:\/\/doi.org\/10.1002\/jmri.26732","journal-title":"J Magn Reson Imaging"},{"key":"5338_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10549-018-4796-9","volume":"170","author":"V Sopik","year":"2018","unstructured":"Sopik V, Narod SA (2018) The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Res Treat 170:647\u2013656. \n                    https:\/\/doi.org\/10.1007\/s10549-018-4796-9","journal-title":"Breast Cancer Res Treat"},{"key":"5338_CR36","doi-asserted-by":"publisher","first-page":"20170907","DOI":"10.1259\/bjr.20170907","volume":"91","author":"V Mango","year":"2018","unstructured":"Mango V, Bryce Y, Morris EA et al (2018) Commentary\u00a0ACOG practice bulletin July 2017: breast cancer risk assessment and\u00a0screening in average-risk women. Br J Radiol 91:20170907. \n                    https:\/\/doi.org\/10.1259\/bjr.20170907","journal-title":"Br J Radiol"},{"key":"5338_CR37","doi-asserted-by":"publisher","first-page":"S313","DOI":"10.1016\/j.jacr.2018.09.017","volume":"15","author":"BL Niell","year":"2018","unstructured":"Expert Panel on Breast Imaging, Niell BL, Lourenco AP et al (2018) ACR appropriateness criteria\u00ae evaluation of the\u00a0symptomatic male breast. J Am Coll Radiol 15:S313\u2013S320. \n                    https:\/\/doi.org\/10.1016\/j.jacr.2018.09.017","journal-title":"J Am Coll Radiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05338-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T23:12:28Z","timestamp":1593904348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["5338"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05338-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,6]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"KP received payment for activities not related to the present article including lectures including service on speakers bureaus and for travel\/accommodations\/meeting expenses unrelated to activities listed from the European Society of Breast Imaging (MRI educational course, annual scientific meeting). MSJ has received an honorarium from GE for speaking, and an honorarium for speaking at the Lynn Sage Breast Cancer Symposium and at MD Anderson. EAM has received a grant from GRAIL. The rest of the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As this was a retrospective study, the need for informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}